Colorectal Adenocarcinoma — Trials

Colorectal Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

367 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 114
Recruiting: 64
Ph III recruiting: 4
Growth YoY: −21.2%
Industry share: 15%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (54)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03507998	Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors	unknown	Phase 1	39	Curegenix Inc.INDUSTRY	1	Jul 24, 2020	clinicaltrials
NCT04380103	A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer	unknown	Phase 1 / Phase 2	106	Chinese Academy of Medical SciencesOTHER	1	May 8, 2020	clinicaltrials